Adaptation of antibiotic treatment to clinical practice guidelines in patients aged ≥65 years hospitalised due to community-acquired pneumonia

被引:3
作者
Fernandez-Sierra, M. A. [1 ]
Rueda-Domingo, M. T. [1 ]
Rodriguez-del-Aguila, M. M. [1 ]
Perez-Lozano, M. J. [2 ]
Force, L. [3 ]
Fernandez-Villa, T. [4 ]
Astray, J. [5 ]
Egurrola, M. [6 ]
Castilla, J. [7 ,8 ]
Sanz, F. [9 ]
Toledo, D. [8 ,10 ]
Dominguez, A. [8 ,10 ]
机构
[1] Hosp Univ Virgen de las Nieves, UGC Prevent Promoc & Vigilancia SaLud, Granada, Spain
[2] Hosp VaLme, UGC Prevent Promoc & Vigiiancia SaLud, Seville, Spain
[3] Hosp Mataro, Barcelona, Spain
[4] Univ Leon, Inst Biomed IBIOMED, GIIGAS, Leon, Spain
[5] Consejeria Sanidad Madrid, Madrid, Spain
[6] Hosp GaLdakao, UsansoLo, Vizcaya, Spain
[7] IdiSNA, Inst Salud Publ Navarra, Pamplona, Spain
[8] CIBERESP, Madrid, Spain
[9] Consorci Hosp Gen Univ Valencia, Valencia, Spain
[10] Univ Barcelona, Dept Med, Barcelona, Spain
关键词
Antibiotic treatment; community-acquired pneumonia; correctness; elderly; hospital; MANAGEMENT; ADULTS; IMMUNIZATION; ADHERENCE; DISEASES; THERAPY; SOCIETY; IMPACT;
D O I
10.1017/S0950268818002121
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Early, conforming antibiotic treatment in elderly patients hospitalised for community-acquired pneumonia (CAP) is a key factor in the prognosis and mortality. The objective was to examine whether empirical antibiotic treatment was conforming according to the Spanish Society of Pulmonology and Thoracic Surgery guidelines in these patients. Multicentre study in patients aged >= 65 years hospitalised due to CAP in the 2013-14 and 2014-15 influenza seasons. We collected socio-demographic information, comorbidities, influenza/pneumococcal vaccination history and antibiotics administered using a questionnaire and medical records. Bivariate analyses and multilevel logistic regression were made. In total, 1857 hospitalised patients were included, 82 of whom required intensive care unit (ICU) admission. Treatment was conforming in 51.4% (95% confidence interval (CI) 49.1-53.8%) of patients without ICU admission and was associated with absence of renal failure without haemodialysis (odds ratio (OR) 1.49, 95% CI 1.15-1.95) and no cognitive dysfunction (OR 1.71, 95% CI 1.25-2.35), when the effect of the autonomous community was controlled for. In patients with ICU admission, treatment was conforming in 45.1% (95% CI 34.1-56.1%) of patients and was associated with the hospital visits in the last year (<3 vs. >= 3, OR 2.70, 95% CI 1.03-7.12) and there was some evidence that this was associated with season. Although the reference guidelines are national, wide variability between autonomous communities was found. In patients hospitalised due to CAP, health services should guarantee the administration of antibiotics in a consensual manner that is conforming according to clinical practice guidelines.
引用
收藏
页码:1870 / 1877
页数:8
相关论文
共 50 条
  • [1] Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
    Aliberti, S.
    Blasi, F.
    Zanaboni, A. M.
    Peyrani, P.
    Tarsia, P.
    Gaito, S.
    Ramirez, J. A.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (01) : 128 - 134
  • [2] Treatment of community-acquired pneumonia in hospitalised patients
    Mulazimoglu, L
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 : S63 - S70
  • [3] Time to first antibiotic dose for patients hospitalised with community-acquired pneumonia
    Yahav, Dafna
    Leibovici, Leonard
    Goldberg, Elad
    Bishara, Jihad
    Paul, Mical
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (05) : 410 - 413
  • [4] Criteria for clinical stability in hospitalised patients with community-acquired pneumonia
    Aliberti, Stefano
    Zanaboni, Anna Maria
    Wiemken, Tim
    Nahas, Ahmed
    Uppatla, Srinivas
    Morlacchi, Letizia Corinna
    Peyrani, Paula
    Blasi, Francesco
    Ramirez, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) : 742 - 749
  • [5] Development of quality indicators to evaluate antibiotic treatment of patients with community-acquired pneumonia in Indonesia
    Farida, Helmia
    Rondags, Angelique
    Gasem, M. Hussein
    Leong, Katharina
    Adityana, A.
    van den Broek, Peterhans J.
    Keuter, Monique
    Natsch, Stephanie
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 (04) : 501 - 509
  • [6] Antibiotic treatment outcomes in community-acquired pneumonia
    Cilli, Aykut
    Sayiner, Abdullah
    Celenk, Burcu
    Sakar Coskun, Aysin
    Kilinc, Oguz
    Hazar, Armagan
    Aktas Samur, Anil
    Tasbakan, Sezai
    Waterer, Grant W.
    Havlucu, Yavuz
    Kilic, Oznur
    Tokgoz, Fatma
    Bilge, Ugur
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) : 730 - 736
  • [7] Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters
    Piso, Rein J.
    Arnold, Christiane
    Bassetti, Stefano
    SWISS MEDICAL WEEKLY, 2013, 143
  • [8] Predictors for individual patient antibiotic treatment effect in hospitalized community-acquired pneumonia patients
    Simonetti, A. F.
    van Werkhoven, C. H.
    Schweitzer, V. A.
    Viasus, D.
    Carratala, J.
    Postma, D. F.
    Oosterheert, J. J.
    Bonten, M. J. M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (10) : 774E1 - 774E7
  • [9] Investigating clinical practice in antibiotic therapy for acute community-acquired pneumonia
    Minchella, A.
    Lechiche, C.
    Poujol, H.
    Molinari, N.
    Sotto, A.
    MEDECINE ET MALADIES INFECTIEUSES, 2010, 40 (02): : 100 - 105
  • [10] Clinical Diagnosis, Viral PCR, and Antibiotic Utilization in Community-Acquired Pneumonia
    Afzal, Zeeshan
    Minard, Charles G.
    Stager, Charles E.
    Yu, Victor L.
    Musher, Daniel M.
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (03) : e766 - e772